<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">47789</article-id><article-id pub-id-type="doi">10.7554/eLife.47789</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Human Biology and Medicine</subject></subj-group></article-categories><title-group><article-title>Site-specific phosphorylation and caspase cleavage of GFAP are new markers of Alexander Disease severity</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-141656"><name><surname>Battaglia</surname><given-names>Rachel A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-141657"><name><surname>Beltran</surname><given-names>Adriana S</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-141659"><name><surname>Delic</surname><given-names>Samed</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-93005"><name><surname>Dumitru</surname><given-names>Raluca</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-141658"><name><surname>Robinson</surname><given-names>Jasmine A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-153494"><name><surname>Kabiraj</surname><given-names>Parijat</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-141660"><name><surname>Herring</surname><given-names>Laura E</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-141661"><name><surname>Madden</surname><given-names>Victoria J</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7909-7743</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-141662"><name><surname>Ravinder</surname><given-names>Namritha</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-141663"><name><surname>Willems</surname><given-names>Erik</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-98116"><name><surname>Newman</surname><given-names>Rhonda A</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" id="author-42282"><name><surname>Quinlan</surname><given-names>Roy Andrew</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0644-4123</contrib-id><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-141664"><name><surname>Goldman</surname><given-names>James E</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-141665"><name><surname>Perng</surname><given-names>Ming-Der</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-141666"><name><surname>Inagaki</surname><given-names>Masaki</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-138755"><name><surname>Snider</surname><given-names>Natasha T</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7663-4585</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf5"/></contrib><aff id="aff1"><institution content-type="dept">Department of Cell Biology and Physiology</institution>, <institution>University of North Carolina at Chapel Hill</institution>, <addr-line><named-content content-type="city">Chapel Hill</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Department of Pharmacology</institution>, <institution>University of North Carolina at Chapel Hill</institution>, <addr-line><named-content content-type="city">Chapel Hill</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Human Pluripotent Stem Cell Core Facility</institution>, <institution>University of North Carolina at Chapel Hill</institution>, <addr-line><named-content content-type="city">Chapel Hill</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution content-type="dept">Department of Pathology</institution>, <institution>University of North Carolina at Chapel Hill</institution>, <addr-line><named-content content-type="city">Chapel Hill</named-content></addr-line>, <country>United States</country></aff><aff id="aff5"><institution>Thermo Fisher Scientific</institution>, <addr-line><named-content content-type="city">Carlsbad</named-content></addr-line>, <country>United States</country></aff><aff id="aff6"><institution content-type="dept">Department of Biosciences</institution>, <institution>Durham University</institution>, <addr-line><named-content content-type="city">Durham</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff7"><institution content-type="dept">Department of Pathology</institution>, <institution>Columbia University</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><aff id="aff8"><institution content-type="dept">Institute of Molecular Medicine</institution>, <institution>National Tsing Hua University</institution>, <addr-line><named-content content-type="city">Hsinchu</named-content></addr-line>, <country>Taiwan, Republic of China</country></aff><aff id="aff9"><institution content-type="dept">Department of Physiology</institution>, <institution>Mie University Graduate School of Medicine</institution>, <addr-line><named-content content-type="city">Mie</named-content></addr-line>, <country>Japan</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1880"><name><surname>Shen</surname><given-names>Kang</given-names></name><role>Reviewing editor</role><aff><institution>Howard Hughes Medical Institute, Stanford University</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>ntsnider@med.unc.edu</email> (NS);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>04</day><month>11</month><year>2019</year></pub-date><volume>8</volume><elocation-id>e47789</elocation-id><history><date date-type="received"><day>18</day><month>04</month><year>2019</year></date><date date-type="accepted"><day>04</day><month>11</month><year>2019</year></date></history><permissions><copyright-statement>Â© 2019, Battaglia et al</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Battaglia et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-47789-v1.pdf"/><abstract><p>Alexander Disease (AxD) is a fatal neurodegenerative disorder caused by mutations in glial fibrillary acidic protein (GFAP), which supports the structural integrity of astrocytes. Over 70 GFAP missense mutations cause AxD, but the mechanism linking different mutations to disease-relevant phenotypes remains unknown. We used AxD patient brain tissue and induced pluripotent stem cell (iPSC)-derived astrocytes to investigate the hypothesis that AxD-causing mutations perturb key post-translational modifications (PTMs) on GFAP. Our findings reveal selective phosphorylation of GFAP-Ser13 in patients who died young, independently of the mutation they carried. AxD iPSC-astrocytes accumulated pSer13-GFAP in cytoplasmic aggregates within deep nuclear invaginations, resembling the hallmark Rosenthal fibers observed <italic>in vivo</italic>. Ser13 phosphorylation facilitated GFAP aggregation and was associated with increased GFAP proteolysis by caspase-6. Furthermore, caspase-6 was selectively expressed in young AxD patients, and correlated with the presence of cleaved GFAP. We reveal a novel PTM signature linking different GFAP mutations in infantile AxD.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution>Elise's Corner Fund</institution></institution-wrap></funding-source><award-id>Research Grant</award-id><principal-award-recipient><name><surname>Snider</surname><given-names>Natasha T</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution>United Leukodystrophy Foundation</institution></institution-wrap></funding-source><award-id>Research Grant</award-id><principal-award-recipient><name><surname>Snider</surname><given-names>Natasha T</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000001</institution-id><institution>National Science Foundation</institution></institution-wrap></funding-source><award-id>Graduate Research Fellowship</award-id><principal-award-recipient><name><surname>Battaglia</surname><given-names>Rachel A</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100007890</institution-id><institution>University of North Carolina at Chapel Hill</institution></institution-wrap></funding-source><award-id>Department of Cell Biology and Physiology</award-id><principal-award-recipient><name><surname>Snider</surname><given-names>Natasha T</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>P30 CA016086</award-id><principal-award-recipient><name><surname>Madden</surname><given-names>Victoria J</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Namritha Ravinder, is a paid employee of ThermoFisher Scientific, whose products were used to complete parts of the study.</p></fn><fn fn-type="conflict" id="conf3"><p>Erik Willems, is a paid employee of ThermoFisher Scientific, whose products were used to complete parts of the study.</p></fn><fn fn-type="conflict" id="conf4"><p>Rhonda A Newman, is a paid employee of ThermoFisher Scientific, whose products were used to complete parts of the study. ThermoFisher Scientific had no role in the study design, data analysis, decision to publish, or preparation of the manuscript.</p></fn><fn fn-type="conflict" id="conf5"><p>Natasha T Snider, is a member of the Scientific Advisory Board for Elise's Corner Fund, which supported part of this work.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analyzed during this study are included in the manuscript and supporting files. Source data files have been provided for mass spec results in Figure 1 and Supplemental Figure 6.</p></sec><supplementary-material><ext-link xlink:href="elife-47789-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>